Viemed Healthcare (CVE:VMD) Stock Price Down 2% – What’s Next?
by Kim Johansen · The Markets DailyViemed Healthcare (CVE:VMD – Get Free Report) shares traded down 2% on Tuesday. The stock traded as low as C$4.84 and last traded at C$4.95. Approximately 91,383 shares changed hands during trading, a decline of 54% from the average session volume of 197,608 shares. The stock had previously closed at C$5.05.
Viemed Healthcare Stock Down 2.0%
The stock’s 50-day moving average price is C$4.95 and its 200 day moving average price is C$4.95.
Institutional Investors Weigh In On Viemed Healthcare
A hedge fund recently bought a new stake in Viemed Healthcare stock. Summit Global Investments purchased a new position in shares of Viemed Healthcare (CVE:VMD – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 36,109 shares of the company’s stock, valued at approximately $412,000. Summit Global Investments owned approximately 0.10% of Viemed Healthcare at the end of the most recent reporting period.
About Viemed Healthcare
Viemed Healthcare, Inc, through its subsidiaries, provides in-home health care solutions in the United States. It offers respiratory services and related equipment, including non-invasive ventilators, positive airway pressure machines, and oxygen units, as well as services of respiratory therapists. The company also provides in-home sleep apnea testing to determine the existence of sleep apnea at home. In addition, it leases equipment, including non-invasive ventilators, bi-level devices and CPaP, percussion vests, and various supplies and peripheral equipment, as well as sells medical equipment and patient monitoring services.
Further Reading
- Five stocks we like better than Viemed Healthcare
- CarMax Just Gave Investors a Better Reason to Believe in the Turnaround
- CoreWeave Comes With Risks: Analysts Split on What Matters Most
- Bottlenecking the Future: TSMC Prices Out the Competition
- Fervo Energy Hits Geothermal Milestone: Will It Matter For The Stock?